COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,844 Articles (22,553 medRxiv, 8,291 bioRxiv)

Most recent first Previous |  Page 486: Articles 4851-4860  | Next

Immunogenicity and safety of Biological Es CORBEVAX vaccine as a heterologous booster dose in adult volunteers previously vaccinated with two doses of either COVISHIELD or COVAXIN: A Prospective double-blind randomised phase III clinical study
Thuluva, S., Paradkar, V., Gunneri, S., Yerroju, V., Mogulla, R. R., Venkata Suneetha, P., Turaga, K., Binayke, A., Zaheer, A., Awasti, A., Virkar, R., Narang, M., Nanjappa, P., Mahantshetti, N., Garg, B., Mandal, R.
10.1101/2022.12.29.22284049 — Posted: 2023-01-03
Post-Exposure Prophylaxis with SA58 (anti-COVID-19 monoclonal antibody) Nasal Spray for the prevention of symptomatic Coronavirus Disease 2019 in healthy adult workers: A randomized, single-blind, placebo-controlled clinical study
Song, R., Zeng, G., Yu, J., Meng, X., Chen, X., Li, J., Xie, X., Lian, X., Zhang, Z., Cao, Y., Yin, W., Jin, R.
10.1101/2022.12.28.22283666 — Posted: 2023-01-03
Usability and performance of the MicroGEM Sal6830, an RT-PCR saliva-based point-of-care platform to detect SARS-CoV-2 in primary healthcare settings with non-laboratory trained operators.
Mills, V., Owen Tyson, T., Helton, R., Hill-Collins, P., Hubbard, S., Scott, A., Hickey, J., Root, B. E., O'Brien, R., Conte, J., Stanton, J.-A. L., Chapman, J. D.
10.1101/2023.01.01.22283267 — Posted: 2023-01-03
Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patients
Dewald, F., Prikl, M., Ahmadov, E., Paluschinski, M., Kuehn, J., Elsner, C., Schulte, B., Schlotz, M., Oral, G., Knuefer, J., Bernhard, M., Michael, M., Luxenburger, M., Andree, M., Hennies, M. T., Hafezi, W., Mueller, M. M., Kuempers, P., Risse, J., Kill, C., Manegold, R. K., von Frantzki, U., Schulte, B., Richter, E., Monzon Posadas, W., Graeff, I., Kogej, M., Buening, A., Baum, M., Teipel, F., Mochtarzadeh, B., Wolff, M., Gruell, H., Di Cristanziano, V., Burst, V., Streeck, H., Dittmer, U., Ludwig, S., Timm, J., Klein, F.
10.1101/2022.12.31.22284088 — Posted: 2023-01-03
The illusion of personal health decisions for infectious disease management: disease spread in social contact networks
Michalska-Smith, M., Enns, E., White, L. A., Gilbertson, M. L., Craft, M. E.
10.1101/2023.01.01.22284075 — Posted: 2023-01-03
ACE2 Receptor Decoy is a Potent Prophylactic and Therapeutic for SARS-CoV-2
Tada, T., Dcosta, B. M., Zhou, H., Landau, N. R.
10.1101/2022.12.31.522401 — Posted: 2023-01-02
Lung lipid deposition in pneumonias of viral and non-viral aetiology
Potashnikova, D. M., Tvorogova, A. V., Saidova, A. A., Sotnikova, T. N., Arifulin, E. A., Lipina, T. V., Shirokova, O. M., Melnikov, E. S., Rodina, T. A., Valyaeva, A. A., Zharikova, A. A., Zayratyants, G. O., Zayratyants, O. V., Sheval, E. V., Margolis, L. B., Vasilieva, E. Y.
10.1101/2022.12.30.522299 — Posted: 2023-01-02
An engineered ACE2 decoy broadly neutralizes Omicron subvariants and shows therapeutic effect in SARS-CoV-2-infected cynomolgus macaques
Urano, E., Itoh, Y., Suzuki, T., Sasaki, T., Kishikawa, J.-i., Akamatsu, K., Higuchi, Y., Sakai, Y., Okamura, T., Mitoma, S., Sugihara, F., Takada, A., Kimura, M., Hirose, M., Sasaki, T., Koketsu, R., Tsuji, S., Yanagida, S., Shioda, T., Hara, E., Matoba, S., Matsuura, Y., Kanda, Y., Arase, H., Okada, M., Takagi, J., Kato, T., Hoshino, A., Yasutomi, Y., Saito, A., Okamoto, T.
10.1101/2022.12.29.522275 — Posted: 2023-01-02
Safety and Effectiveness of SA58 Nasal Spray against COVID-19 Infection in Medical Personnel：An Open-label, Blank-controlled Study
Si, S., Jin, C., Cao, Y. R., Li, J., Kan, B., Xue, F., Xie, X. S., Fang, L., Zeng, G., Zhang, S., Hu, Y., Dong, X.
10.1101/2022.12.27.22283698 — Posted: 2022-12-31
COVID-19 in Cambodia: Epidemiology, Response, and Lessons Learned, 27 January 2020 to 30 June 2022
Chhim, S., Ku, G. M., Mao, S., Put, W. v. d., Van Damme, W., Ir, P., Chhea, C., Or, V.
10.1101/2022.12.24.22283920 — Posted: 2022-12-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).